Astria Therapeutics, Inc. (ATXS)
NASDAQ: ATXS · IEX Real-Time Price · USD
10.54
-0.01 (-0.09%)
Apr 18, 2024, 4:00 PM EDT - Market closed
Astria Therapeutics Market Cap
Astria Therapeutics has a market cap or net worth of $578.68 million as of April 18, 2024. Its market cap has increased by 69.90% in one year.
Market Cap
578.68M
Enterprise Value
332.48M
1-Year Change
69.90%
Ranking
Category
Stock Price
$10.54
Market Cap Chart
Since June 25, 2015, Astria Therapeutics's market cap has increased from $180.00M to $578.68M, an increase of 221.49%. That is a compound annual growth rate of 14.16%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 17, 2024 | 579.20M | -4.96% |
Apr 16, 2024 | 609.40M | 1.92% |
Apr 15, 2024 | 597.90M | 0.74% |
Apr 12, 2024 | 593.50M | -4.00% |
Apr 11, 2024 | 618.20M | 0.80% |
Apr 10, 2024 | 613.30M | -2.77% |
Apr 9, 2024 | 630.80M | 0.78% |
Apr 8, 2024 | 625.90M | 1.15% |
Apr 5, 2024 | 618.80M | -2.34% |
Apr 4, 2024 | 633.60M | -4.62% |
Apr 3, 2024 | 664.30M | -5.48% |
Apr 2, 2024 | 702.80M | -5.24% |
Apr 1, 2024 | 741.70M | -4.02% |
Mar 28, 2024 | 772.80M | 3.50% |
Mar 27, 2024 | 746.70M | 0.53% |
Mar 26, 2024 | 742.80M | -8.27% |
Mar 25, 2024 | 809.80M | -2.52% |
Mar 22, 2024 | 830.70M | -5.38% |
Mar 21, 2024 | 877.90M | 1.71% |
Mar 20, 2024 | 863.10M | -5.81% |
Mar 19, 2024 | 916.30M | 6.92% |
Mar 18, 2024 | 857.00M | 0.97% |
Mar 15, 2024 | 848.80M | 5.82% |
Mar 14, 2024 | 802.10M | -2.60% |
Mar 13, 2024 | 823.50M | 3.58% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Fulgent Genetics | 617.14M |
Nuvation Bio | 612.71M |
Lyell Immunopharma | 612.37M |
Mobile-health Network Solutions | 612.00M |
Canopy Growth | 610.47M |
Absci | 606.78M |
Quanterix | 606.73M |
Olema Pharmaceuticals | 605.00M |